Blockade of PDGFR-β2 activation eliminates morphine analgesic tolerance

Yan Wang, Katherine Barker, Shanping Shi, Miguel Diaz, Bing Mo, Howard B. Gutstein

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

For centuries, opioid drugs have been the mainstay of chronic pain treatment. However, over time analgesic tolerance develops, leaving few treatment options. Here we show that platelet-derived growth factor receptor-β2 (PDGFR-β2)-mediated signaling plays a key role in morphine tolerance. PDGFR-β2 inhibition selectively eliminates morphine tolerance in rats. PDGFR-β2 inhibitors are widely used and well tolerated, suggesting that clinical translation of our findings could reduce the suffering endured by individuals with intractable pain.

Original languageEnglish (US)
Pages (from-to)385-387
Number of pages3
JournalNature medicine
Volume18
Issue number3
DOIs
StatePublished - Mar 2012

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Blockade of PDGFR-β2 activation eliminates morphine analgesic tolerance'. Together they form a unique fingerprint.

Cite this